Polianta Ltd’s Chemours CC Stock Holding History

Polianta Ltd’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,900	Closed	-$1.1M	–	63
2018 Q3	$1.1M	Buy	27,900 +4,200	+18%	+$184K	0.55%	61
2018 Q2	$1.05M	Buy	+23,700	New	+$1.18M	0.33%	70

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Polianta Ltd's CC Position: Q4 2018 in Review

Polianta Ltd sold out of Chemours (CC) in Q4 2018, closing a stake of 27,900 shares — an estimated $1.1M sold.

Polianta Ltd first reported a position in CC in Q2 2018 and held it in 2 quarters. The position peaked at $1.1M in Q3 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

Polianta Ltd reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
Polianta Ltd sold 27,900 Chemours shares in Q4 2018, an estimated $1.1M.
Polianta Ltd first reported a position in Chemours in Q2 2018 and held it in 2 quarters.
Polianta Ltd's Chemours position peaked at $1.1M in Q3 2018.
506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Polianta Ltd's 13F filing for Q4 2018, filed 15 Jan 2019.